MONTELUKAST Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Montelukast, and what generic alternatives are available?
Montelukast is a drug marketed by Ajanta Pharma Ltd, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Pharmobedient, Teva Pharms, Torrent, Aiping Pharm Inc, Amneal Pharms, Anbison Lab, Apotex Inc, Chartwell Molecular, Hetero Labs Ltd V, Hikma, Jubilant Generics, Lannett Co Inc, Macleods Pharms Ltd, Natco Pharma, Pharmaco, Rising, Senores Pharms, Torrent Pharms Ltd, Unichem, Accord Hlthcare, Apotex Corp, Breckenridge, Cipla, Glenmark Pharms Ltd, L Perrigo Co, Sandoz Inc, and Strides Pharma Intl. and is included in forty-nine NDAs.
The generic ingredient in MONTELUKAST is montelukast sodium. There are thirty-five drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the montelukast sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Montelukast
A generic version of MONTELUKAST was approved as montelukast sodium by AUROBINDO PHARMA LTD on August 3rd, 2012.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MONTELUKAST?
- What are the global sales for MONTELUKAST?
- What is Average Wholesale Price for MONTELUKAST?
Summary for MONTELUKAST
| US Patents: | 0 |
| Applicants: | 30 |
| NDAs: | 49 |
| Drug Prices: | Drug price information for MONTELUKAST |
| Drug Sales Revenues: | Drug sales revenues for MONTELUKAST |
| DailyMed Link: | MONTELUKAST at DailyMed |
US Patents and Regulatory Information for MONTELUKAST
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms | MONTELUKAST SODIUM | montelukast sodium | TABLET, CHEWABLE;ORAL | 078723-001 | Aug 3, 2012 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Natco Pharma | MONTELUKAST SODIUM | montelukast sodium | TABLET, CHEWABLE;ORAL | 079142-002 | Aug 3, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Amneal Pharms | MONTELUKAST SODIUM | montelukast sodium | TABLET;ORAL | 204604-001 | Sep 4, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| L Perrigo Co | MONTELUKAST SODIUM | montelukast sodium | TABLET;ORAL | 206112-001 | Apr 26, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Unichem | MONTELUKAST SODIUM | montelukast sodium | TABLET, CHEWABLE;ORAL | 208621-001 | Jul 2, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
